ArticleFrontiers in nutrition2026
Clinical implications of malnutrition in Huntington's disease progression: evidence from a Chinese cohort and Mendelian randomization.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Huntington's disease (HD) is a neurodegenerative disorder associated with progressive motor, cognitive, and psychiatric dysfunction. Peripheral metabolic disturbances, including malnutrition, are commonly observed in HD. However, the prevalence, clinical correlations, and prognostic value of malnutrition in HD, especially among Chinese patients, remain inadequately explored. Methods: This cohort study recruited 113 genetically confirmed HD patients and 113 age/sex-matched healthy controls (HCs). Nutritional status was assessed using the Controlling Nutritional Status (CONUT) score, Geriatric Nutritional Risk Index (GNRI), and Prognostic Nutritional Index (PNI). Clinical evaluations included Unified Huntington's Disease Rating Scale (UHDRS), cognitive tests, and psychiatric assessments. Kaplan-Meier survival analysis and Cox regression models were used to evaluate the prognostic significance of malnutrition. Mendelian randomization (MR) analysis was employed to explore causal relationships between nutritional indicators and HD progression using genome-wide association study (GWAS) data. Results: During a mean follow-up of 5.74 years, 44 patients reached composite endpoints of death or loss of independent function [total functional capacity (TFC) ≤ 2]. HD patients showed higher malnutrition prevalence than HCs (CONUT: 34.51 vs. 13.27%; GNRI: 7.96 vs. 2.65%). Malnutrition correlated with functional decline, cognitive impairment, advanced disease stage, and lower composite Unified Huntington's Disease Rating Scale (cUHDRS) score, but not with survival outcomes. MR analysis suggests a causal relationship between lymphocyte count and delayed motor progression in HD patients. Conclusion: Malnutrition was highly prevalent in Chinese HD patients and was associated with functional and cognitive decline. Although malnutrition did not independently predict survival, MR analysis suggests that lymphocytes delay motor progression, implying that immunonutritional pathways may warrant further investigation as potential targets for future mechanistic and interventional research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.